To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C9orf30andTMEFF1andMURCTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
310 supporting clones for gene C9orf30andTMEFF1andMURC back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
C14397   .a 2167 to 2537 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
C14398   .a 1248 to 1700 1 to 452       452/452
(100 %)
1 diff
(99.8 %id)
C14418   .a 1247 to 1607 1 to 361       361/364
(99 %)
2 diff
(99.5 %id)
C14446   .a 2132 to 2537 405 to 1       405/405
(100 %)
1 diff
(99.8 %id)
C14488   .a 1248 to 1462 1 to 216       216/216
(100 %)
5 diff
(97.7 %id)
C14503   .a 1249 to 1599 1 to 350       350/350
(100 %)
8 diff
(97.8 %id)
C18056 placenta .a 933 to 1327 1 to 395       395/395
(100 %)
0 diff
(100 %id)
AA757140   .e 912 to 1342 433 to 3       431/433
(99 %)
0 diff
(100 %id)
Z28835 leg muscle, skeletal muscle .a 2956 to 3241 1 to 286       286/286
(100 %)
2 diff
(99.4 %id)
AA297030   .a 712 to 992 9 to 291       283/292
(96 %)
12 diff
(95.9 %id)
AA297256 Embryo, 8 weeks .a 1209 to 1415 1 to 207       207/207
(100 %)
0 diff
(100 %id)
AA297316 Embryo, 8 weeks .a 1209 to 1530 1 to 325       325/326
(99 %)
5 diff
(98.5 %id)
AA302154 aorta .e 537 to 881 1 to 346       346/348
(99 %)
3 diff
(99.2 %id)
AA309408 aorta .e 506 to 842 1 to 336       336/336
(100 %)
1 diff
(99.8 %id)
AA373648 lung .e 1012 to 1314 1 to 303       303/303
(100 %)
0 diff
(100 %id)
AI110777 Liver .e 454 to 1144 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
AJ707712 heart .a 4624 to 5159 1 to 535       535/535
(100 %)
4 diff
(99.3 %id)
AK092292 tongue .n 588 to 2578 1 to 1991   tiling clone, available from FLJ,   1991/1991
(100 %)
5 diff
(99.8 %id)
AK128238 testis .j-u 8 to 4218 1 to 4211   tiling clone, available from FLJ,   4211/4234
(99 %)
9 diff
(99.8 %id)
AK300099 pericardium .a 2981 to 4414 1 to 1435       1435/1435
(100 %)
3 diff
(99.8 %id)
AK314924 subthalamic nucleus .e 173 to 1074 1 to 902 F13S     902/902
(100 %)
2 diff
(99.8 %id)
AL831919 amygdala .a 470 to 2537 1 to 2068   tiling clone, available from DKFZ, AAA   2068/2068
(100 %)
0 diff
(100 %id)
AW371297 breast .e 929 to 1392 1 to 465       465/465
(100 %)
7 diff
(98.5 %id)
AW380873 head_neck .e 914 to 1392 477 to 1       477/496
(96 %)
14 diff
(97.2 %id)
AW380920 head_neck .e 914 to 1398 508 to 19       490/552
(88 %)
0 diff
(100 %id)
AW381554 head_neck .e 914 to 1151 238 to 1       238/254
(93 %)
2 diff
(99.3 %id)
AW381560 head_neck .e 914 to 1240 327 to 1       327/340
(96 %)
3 diff
(99.2 %id)
AW896528 nervous_normal .a 2169 to 2367 205 to 4       202/205
(98 %)
0 diff
(100 %id)
AW950489   .a 1210 to 1794 1 to 589       589/601
(98 %)
18 diff
(97.1 %id)
AW957515   .e 1013 to 1450 1 to 437       437/438
(99 %)
2 diff
(99.6 %id)
AY598327   .e 247 to 1074 1 to 828 exact     828/828
(100 %)
0 diff
(100 %id)
BC008993 Brain, glioblastoma with EGFR amplification .e 180 to 1337 1 to 1158 exact available from MGC, AAA   1158/1158
(100 %)
0 diff
(100 %id)
BC035056 Brain, hippocampus .b 327 to 2611 1 to 2283 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2283/2283
(100 %)
4 diff
(99.9 %id)
BC090888 Muscle pool- 2 tissues- cardiac and skeletalmuscle. .a 3064 to 5578 1 to 2515   tiling clone, AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 2515/2515
(100 %)
4 diff
(99.9 %id)
BE005681 breast_normal .a 1134 to 1710 1 to 576       576/581
(99 %)
13 diff
(97.8 %id)
BE005802 breast_normal .a 1123 to 1684 560 to 1     Submitted on the opposite strand 560/560
(100 %)
3 diff
(99.5 %id)
BE005821 breast_normal .a 1166 to 1674 511 to 3     Submitted on the opposite strand 509/511
(99 %)
1 diff
(99.9 %id)
BE173261 head_neck .e 1210 to 1393 13 to 198       186/198
(93 %)
6 diff
(97.0 %id)
BF083570 colon .e 1143 to 1338 203 to 8       196/203
(96 %)
0 diff
(100 %id)
BF229110 amnion_normal .a 590 to 925 340 to 4       337/355
(94 %)
1 diff
(99.8 %id)
BF825728 head_normal .a 4206 to 4362 1 to 157       157/157
(100 %)
11 diff
(93.0 %id)
BG186611   .p-u 48 to 407 1 to 363       363/363
(100 %)
13 diff
(96.5 %id)
BG192849   .m 1 to 260 1 to 260 S2C T5I tiling clone,   260/260
(100 %)
5 diff
(98.1 %id)
BG200426   .p-u 58 to 335 55 to 329       275/330
(83 %)
5 diff
(98.5 %id)
BG202527   .p-u 46 to 729 1 to 684 I12T E47V AAA   684/684
(100 %)
28 diff
(96.0 %id)
BG214092   .p-u 57 to 729 7 to 677 I12T E47V AAA   671/677
(99 %)
10 diff
(98.6 %id)
BQ327416 heart_neonatal .e 181 to 553 373 to 1       373/392
(95 %)
1 diff
(99.8 %id)
DA111182 cerebellum .e 824 to 1415 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA190495 amygdala .a 1114 to 1680 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA251649 caudate nucleus .l 1 to 572 2 to 573 exact tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
DA293094 hippocampus .f 202 to 768 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA294795 hippocampus .f 208 to 780 2 to 574   tiling clone, capped   573/574
(99 %)
1 diff
(99.9 %id)
DA367330 subthalamic nucleus .e 174 to 655 2 to 483   capped   482/482
(100 %)
2 diff
(99.6 %id)
BU101920   .a 3287 to 3897 1 to 611       611/611
(100 %)
3 diff
(99.6 %id)
BU101921   .a 4549 to 4915 367 to 1       367/367
(100 %)
2 diff
(99.5 %id)
BX107846 liver and spleen .d 1043 to 1714 1 to 667       667/669
(99 %)
5 diff
(99.3 %id)
BX281689 pooled .a 3775 to 4275 1 to 501       501/501
(100 %)
2 diff
(99.7 %id)
DA424604   .n 197 to 756 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CN274988 embryonic stem cells, DMSO-treated H9 cellline .a 1489 to 2060 1 to 572       572/573
(99 %)
6 diff
(99.0 %id)
CN274989 embryonic stem cells, DMSO-treated H9 cellline .a 895 to 1366 4 to 475       472/475
(99 %)
6 diff
(98.8 %id)
CN274990 embryonic stem cells, DMSO-treated H9 cellline .a 679 to 906 1 to 228       228/228
(100 %)
2 diff
(99.2 %id)
CN274991 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 620 to 1192 13 to 586       574/586
(97 %)
6 diff
(99.0 %id)
CN274992 embryonic stem cells, DMSO-treated H9 cellline .b 546 to 957 1 to 412       412/445
(92 %)
1 diff
(99.8 %id)
CN274993 embryonic stem cells, cell lines H1, H7, andH9 .a 843 to 1417 1 to 575       575/575
(100 %)
0 diff
(100 %id)
CN274994 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1326 to 1981 1 to 657       657/657
(100 %)
6 diff
(99.1 %id)
CN366266 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 1 to 620 1 to 620 exact tiling clone,   620/620
(100 %)
2 diff
(99.7 %id)
CN366267 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1 to 548 1 to 548   tiling clone,   548/548
(100 %)
0 diff
(100 %id)
CN430248 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3568 to 4316 13 to 761       749/761
(98 %)
9 diff
(98.9 %id)
CR595218 HeLa cells Cot 25-normalized .d 1197 to 1753 1 to 557       557/557
(100 %)
0 diff
(100 %id)
CR599657 adult brain .e 211 to 1438 1 to 1228 exact     1228/1228
(100 %)
0 diff
(100 %id)
CR601135 Neuroblastoma Cot 10-normalized .e 211 to 1801 1 to 1591 exact     1591/1591
(100 %)
0 diff
(100 %id)
CR608769 Neuroblastoma Cot 50-normalized .e 1 to 1819 1 to 1819 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1819/1819
(100 %)
0 diff
(100 %id)
CR616245 T cells (Jurkat cell line) .e 92 to 1308 1 to 1217 exact     1217/1217
(100 %)
0 diff
(100 %id)
CR737080   .q-u 37 to 522 486 to 1 exact tiling clone, Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
AL520073 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 813 to 1727 906 to 1   fully sequenced,   906/906
(100 %)
10 diff
(98.9 %id)
AL520074 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 137 to 843 1 to 698   fully sequenced,   698/698
(100 %)
1 diff
(99.9 %id)
BX329529 Neuroblastoma Cot 25-normalized .d 874 to 1759 898 to 1       898/901
(99 %)
45 diff
(95.1 %id)
BX332194 Neuroblastoma Cot 25-normalized .d 729 to 1704 999 to 35       965/999
(96 %)
0 diff
(100 %id)
AL528730 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 882 to 1798 944 to 34   fully sequenced, AAA   911/934
(97 %)
3 diff
(99.7 %id)
AL528731 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 1 to 912 1 to 895   fully sequenced,   895/895
(100 %)
5 diff
(99.5 %id)
BX440169 brain, fetal brain .a 2106 to 2509 404 to 1       804/938
(85 %)
70 diff
(92.6 %id)
BX418400 brain, fetal brain .d 1324 to 1716 394 to 1       819/847
(96 %)
33 diff
(96.2 %id)
BX454718 brain, fetal brain .d 1068 to 1763 695 to 1       695/939
(74 %)
13 diff
(98.7 %id)
BX413500 brain, fetal brain .a 2115 to 2520 417 to 13       405/466
(86 %)
0 diff
(100 %id)
BX452188 brain, fetal brain .a 788 to 1635 1 to 846       846/849
(99 %)
8 diff
(99.1 %id)
BX461269 brain, fetal brain .b 1 to 1002 1 to 1001       1001/1001
(100 %)
10 diff
(99.1 %id)
BX405296 T cells (Jurkat cell line) .e 963 to 1308 344 to 1   fully sequenced,   344/344
(100 %)
11 diff
(96.9 %id)
BX426582 T cells (Jurkat cell line) .e 92 to 993 1 to 898   fully sequenced,   898/898
(100 %)
9 diff
(99.0 %id)
BX328131   .d 1613 to 1753 1 to 138       138/138
(100 %)
4 diff
(97.2 %id)
BX342336   .d 1197 to 1767 1 to 571   tiling clone,   571/571
(100 %)
11 diff
(98.1 %id)
BX410267 adult brain, brain .e 840 to 1418 10 to 587       578/605
(95 %)
26 diff
(95.8 %id)
BX410268 adult brain, brain .e 865 to 1528 1 to 665       665/843
(78 %)
27 diff
(96.8 %id)
BX423131 adult brain, brain .d 775 to 1705 947 to 1       947/956
(99 %)
22 diff
(97.7 %id)
BX423132 adult brain, brain .e 211 to 966 1 to 755       755/755
(100 %)
9 diff
(98.9 %id)
CV024841 mixed .b 437 to 1095 1 to 654       654/654
(100 %)
8 diff
(98.8 %id)
CV025197 mixed .e 247 to 861 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BX473604   .e 186 to 794 1 to 615       615/615
(100 %)
8 diff
(98.7 %id)
BX472510   .p-u 51 to 640 20 to 610 exact     591/610
(96 %)
6 diff
(99.1 %id)
AL134866 melanoma (MeWo cell line) .a 918 to 1481 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
DN915429   .d 1328 to 1766 437 to 1       437/444
(98 %)
17 diff
(96.2 %id)
DN915430   .d 1333 to 1745 1 to 411   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 411/411
(100 %)
6 diff
(98.6 %id)
DW460252 Liver .k 487 to 619 8 to 140       133/140
(95 %)
6 diff
(95.8 %id)
EB362110 eye, lens .e 910 to 1339 439 to 11       429/440
(97 %)
0 diff
(100 %id)
EU487253 heart .a 3046 to 4140 1 to 1095   tiling clone,   1095/1095
(100 %)
0 diff
(100 %id)
T19015   .f 87 to 384 12 to 310       299/310
(96 %)
6 diff
(98.1 %id)
D59486   .a 2278 to 2458 260 to 80       181/185
(97 %)
0 diff
(100 %id)
D59487   .a 1253 to 1561 6 to 313       308/313
(98 %)
7 diff
(97.8 %id)
D59541   .a 2207 to 2537 329 to 1       329/336
(97 %)
3 diff
(99.2 %id)
D59542   .a 1247 to 1559 1 to 313       313/313
(100 %)
5 diff
(98.5 %id)
D59607   .a 1248 to 1682 1 to 433       433/444
(97 %)
2 diff
(99.6 %id)
D59667   .a 2176 to 2537 360 to 1       360/360
(100 %)
3 diff
(99.2 %id)
D59702   .a 2282 to 2537 257 to 1       257/257
(100 %)
5 diff
(98.1 %id)
D59704   .a 1248 to 1614 1 to 367       367/370
(99 %)
3 diff
(99.2 %id)
D59706   .a 2131 to 2537 405 to 1       405/405
(100 %)
2 diff
(99.6 %id)
D59707   .a 1248 to 1750 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
D59724   .a 1253 to 1675 6 to 429       424/429
(98 %)
7 diff
(98.4 %id)
D59771   .a 2131 to 2537 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
D59783   .a 2134 to 2537 404 to 1       404/409
(98 %)
1 diff
(99.8 %id)
D59799   .a 1253 to 1560 7 to 325       319/325
(98 %)
9 diff
(97.3 %id)
D59822 brain .a 2279 to 2538 259 to 1       259/259
(100 %)
4 diff
(98.5 %id)
D80377 brain .a 1248 to 1607 1 to 359       359/362
(99 %)
4 diff
(98.9 %id)
D59830   .a 2116 to 2537 421 to 1       421/421
(100 %)
8 diff
(98.1 %id)
D59831   .a 1248 to 1577 1 to 327       327/327
(100 %)
6 diff
(98.2 %id)
D60176   .a 1278 to 1559 1 to 283       283/283
(100 %)
5 diff
(98.3 %id)
D81838 brain .a 586 to 1129 1 to 541       541/541
(100 %)
5 diff
(99.1 %id)
AV653219 corresponding non cancerous liver tissue .a 1215 to 1890 1 to 674     Submitted on the opposite strand 674/674
(100 %)
3 diff
(99.6 %id)
DB458389 testis .b 103 to 576 1 to 474       474/480
(98 %)
2 diff
(99.6 %id)
DB523885 testis .a 4133 to 4584 1 to 452     Submitted on the opposite strand 452/452
(100 %)
1 diff
(99.8 %id)
DB527928 testis .d 1298 to 1766 1 to 470     Submitted on the opposite strand 470/470
(100 %)
5 diff
(99.0 %id)
DB493360 hypothalamus .b 44 to 538 1 to 494       494/494
(100 %)
4 diff
(99.2 %id)
DB564449 hypothalamus .a 2086 to 2534 1 to 449     Submitted on the opposite strand 449/449
(100 %)
2 diff
(99.6 %id)
DB494600 hypothalamus .b 44 to 556 1 to 512       512/512
(100 %)
3 diff
(99.5 %id)
DB565651 hypothalamus .a 2064 to 2534 1 to 473     Submitted on the opposite strand 473/473
(100 %)
7 diff
(98.6 %id)
DB576218 hypothalamus .a 2045 to 2534 1 to 491     Submitted on the opposite strand 491/491
(100 %)
7 diff
(98.6 %id)
AF074684 Liver .e 454 to 1144 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
DC355035   .a 3066 to 3627 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BY797010 eye .b 85 to 570 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BP258941 heart .a 718 to 1283 1 to 566       566/566
(100 %)
0 diff
(100 %id)
R52613 whole brain .a 2125 to 2538 425 to 9       417/427
(97 %)
0 diff
(100 %id)
R53268 whole brain .a 668 to 788 1 to 121       121/121
(100 %)
0 diff
(100 %id)
R66003 placenta .a 1732 to 2184 1 to 461       461/463
(99 %)
25 diff
(94.7 %id)
H96998 melanocyte .e 1054 to 1376 335 to 1   fully sequenced,   335/335
(100 %)
3 diff
(99.2 %id)
H97115 melanocyte .e 955 to 1384 1 to 437   fully sequenced,   437/437
(100 %)
16 diff
(96.4 %id)
N40940 multiple sclerosis lesions .a 2074 to 2537 472 to 1       472/473
(99 %)
16 diff
(96.7 %id)
N46797 multiple sclerosis lesions .a 1675 to 2002 1 to 328       328/328
(100 %)
1 diff
(99.7 %id)
N66608 multiple sclerosis lesions .a 2135 to 2537 406 to 1       406/406
(100 %)
5 diff
(98.8 %id)
N66623 multiple sclerosis lesions .a 2205 to 2537 333 to 1       333/335
(99 %)
1 diff
(99.8 %id)
W58229 heart .a 4547 to 4920 1 to 375   tiling clone, fully sequenced,   375/375
(100 %)
1 diff
(99.8 %id)
W58230 heart .a 4890 to 5282 392 to 1   fully sequenced,   392/392
(100 %)
5 diff
(98.8 %id)
W88667 liver and spleen .d 1417 to 1766 348 to 1   fully sequenced,   348/348
(100 %)
1 diff
(99.8 %id)
W88873 liver and spleen .d 1044 to 1447 1 to 403   fully sequenced,   403/403
(100 %)
4 diff
(99.1 %id)
W90542 liver and spleen .d 1044 to 1444 1 to 398   fully sequenced,   398/398
(100 %)
5 diff
(98.8 %id)
W90543 liver and spleen .d 1414 to 1766 356 to 1   fully sequenced,   356/356
(100 %)
4 diff
(98.9 %id)
AA001144 liver and spleen .d 1043 to 1507 1 to 463   fully sequenced,   463/463
(100 %)
6 diff
(98.8 %id)
AA001949 liver and spleen .d 1477 to 1766 292 to 1   fully sequenced,   292/292
(100 %)
1 diff
(99.7 %id)
AA084788   .a 1190 to 1349 1 to 160       160/160
(100 %)
0 diff
(100 %id)
AA127459 lung, lung carcinoma .d 1601 to 1783 182 to 1   tiling clone, fully sequenced,   182/182
(100 %)
5 diff
(97.3 %id)
AA127601 lung, lung carcinoma .d 1302 to 1631 1 to 336   fully sequenced,   336/336
(100 %)
7 diff
(98.0 %id)
AA130346   .e 1074 to 1327 254 to 1     Submitted on the opposite strand 254/254
(100 %)
0 diff
(100 %id)
AA130347   .f 108 to 528 1 to 426     Submitted on the opposite strand 426/427
(99 %)
15 diff
(96.5 %id)
AA192639 muscle, skeletal muscle .a 2845 to 3271 1 to 431   tiling clone,   431/431
(100 %)
5 diff
(98.9 %id)
AA192640 muscle, skeletal muscle .a 5116 to 5565 450 to 1       450/461
(97 %)
5 diff
(99.0 %id)
AA214322   .e 1552 to 1818 272 to 1       272/290
(93 %)
10 diff
(96.6 %id)
AA214364   .e 483 to 788 1 to 305       305/306
(99 %)
5 diff
(98.4 %id)
AA214409   .e 483 to 662 1 to 182       182/183
(99 %)
12 diff
(93.5 %id)
AA214410   .e 1425 to 1819 395 to 1       395/395
(100 %)
2 diff
(99.5 %id)
AA232350.
matches multiple genes
brain, neuroepithelial cells .b 519 to 875 1 to 356     also hits gene GCOM1andGRINL1A 356/356
(100 %)
3 diff
(99.2 %id)
AA193344 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .p-u 59 to 352 1 to 294   fully sequenced,   294/294
(100 %)
3 diff
(99.0 %id)
AA193462 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .p-u 322 to 678 357 to 1   fully sequenced,   357/357
(100 %)
0 diff
(100 %id)
AA227523 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1022 to 1398 376 to 1   fully sequenced,   376/376
(100 %)
0 diff
(100 %id)
AA227644 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 956 to 1376 1 to 420   fully sequenced,   420/420
(100 %)
1 diff
(99.8 %id)
AA262346 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1007 to 1397 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AA431475   .a 2263 to 2536 276 to 3       274/276
(99 %)
0 diff
(100 %id)
AA431678   .a 886 to 1216 1 to 332       332/332
(100 %)
3 diff
(99.1 %id)
AA679236   .a 3913 to 4291 379 to 1       379/379
(100 %)
1 diff
(99.8 %id)
AA584272 colon, colon tumor RER+ .a 2113 to 2535 442 to 20   AAA   423/423
(100 %)
0 diff
(100 %id)
AA760639 germinal center B cell .f 122 to 267 1 to 146     Submitted on the opposite strand 146/146
(100 %)
0 diff
(100 %id)
AA831401 germinal center B cell .p-u 1 to 421 1 to 421   tiling clone, Submitted on the opposite strand 421/421
(100 %)
0 diff
(100 %id)
AA741509 germinal center B cell .p-u 5 to 414 1 to 410     Submitted on the opposite strand 410/410
(100 %)
1 diff
(99.8 %id)
AA862759 pooled germ cell tumors .a 2163 to 2538 376 to 1       376/376
(100 %)
1 diff
(99.8 %id)
AI094181 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 993 to 1397 405 to 1       405/405
(100 %)
0 diff
(100 %id)
AI240420 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1074 to 1398 325 to 1       325/325
(100 %)
0 diff
(100 %id)
AI224842 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 989 to 1398 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AI288886 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 957 to 1397 453 to 13   AAA   441/441
(100 %)
0 diff
(100 %id)
AI492928 Kidney .d 1303 to 1745 1 to 442     Submitted on the opposite strand 442/451
(98 %)
2 diff
(99.6 %id)
AI382321   .a 2279 to 2538 273 to 14       260/273
(95 %)
0 diff
(100 %id)
AI868482 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1514 to 1766 253 to 1       253/253
(100 %)
1 diff
(99.7 %id)
AI539416 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1373 to 1768 401 to 6       396/402
(98 %)
0 diff
(100 %id)
AI417635 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 986 to 1339 356 to 3       354/356
(99 %)
0 diff
(100 %id)
AI435978 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1020 to 1397 378 to 1       378/378
(100 %)
2 diff
(99.5 %id)
AI623842 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k 645 to 1055 411 to 1   tiling clone,   411/411
(100 %)
0 diff
(100 %id)
AI718525 aorta .e 1248 to 1341 94 to 1       94/94
(100 %)
0 diff
(100 %id)
AI911734 pooled .r-u 1 to 506 506 to 1 exact tiling clone,   506/506
(100 %)
1 diff
(99.9 %id)
AI741117 pooled .d 1211 to 1766 566 to 11   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 556/556
(100 %)
1 diff
(99.9 %id)
AI761849 pooled .e 912 to 1342 435 to 5       431/435
(99 %)
0 diff
(100 %id)
AI864040 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f 92 to 536 1 to 446   tiling clone, Submitted on the opposite strand 446/448
(99 %)
4 diff
(99.2 %id)
AI857678 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2267 to 2538 273 to 2       272/273
(99 %)
0 diff
(100 %id)
AI857684 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2272 to 2538 268 to 2       267/268
(99 %)
0 diff
(100 %id)
AI924607 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .e 216 to 720 1 to 505     Submitted on the opposite strand 505/505
(100 %)
2 diff
(99.7 %id)
AW050404 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2347 to 2537 191 to 1       191/191
(100 %)
0 diff
(100 %id)
AW148791 brain, tumor, 5 pooled (see description) .a 2102 to 2537 436 to 1       436/436
(100 %)
0 diff
(100 %id)
AW236021 Kidney .f 89 to 447 20 to 378     Submitted on the opposite strand 359/378
(94 %)
6 diff
(98.5 %id)
AW139617   .d 1349 to 1768 1 to 420     Submitted on the opposite strand 420/430
(97 %)
1 diff
(99.8 %id)
AW275198 lung, two pooled squamous cell carcinomas .d 1495 to 1766 272 to 1       272/272
(100 %)
1 diff
(99.7 %id)
BE301253 Kidney, renal cell adenocarcinoma .e 908 to 1339 432 to 1       432/432
(100 %)
0 diff
(100 %id)
BE301262 Kidney, renal cell adenocarcinoma .e 956 to 1338 383 to 1       383/383
(100 %)
2 diff
(99.5 %id)
AW769281 colon, moderately-differentiated adenocarcinoma .d 1267 to 1767 495 to 1       495/495
(100 %)
7 diff
(98.6 %id)
BE018216 cervical carcinoma cell line, cervix .d 897 to 1330 1 to 434   fully sequenced,   434/434
(100 %)
0 diff
(100 %id)
BE301701 cervical carcinoma cell line, cervix .d 1300 to 1745 446 to 1   fully sequenced,   446/446
(100 %)
0 diff
(100 %id)
BE328217 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 2211 to 2536 326 to 1       326/326
(100 %)
1 diff
(99.7 %id)
BE328260 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 2103 to 2537 435 to 1       435/435
(100 %)
0 diff
(100 %id)
BE467382 carcinoid, lung .d 1349 to 1725 1 to 378     Submitted on the opposite strand 378/378
(100 %)
3 diff
(99.3 %id)
CB047340 Kidney .e 855 to 1330 503 to 26   AAA   478/478
(100 %)
2 diff
(99.6 %id)
CB047341 Kidney .e 189 to 839 10 to 660       651/660
(98 %)
3 diff
(99.6 %id)
BF436262 pooled .a 2201 to 2537 353 to 17   AAA   337/337
(100 %)
0 diff
(100 %id)
BF439316 pooled .a 1979 to 2538 562 to 3       560/562
(99 %)
0 diff
(100 %id)
BE645548 Prostate .d 108 to 646 1 to 539     Submitted on the opposite strand 539/539
(100 %)
0 diff
(100 %id)
BF061524 pooled .a 3793 to 4298 515 to 10       506/515
(98 %)
0 diff
(100 %id)
BG150431 pooled germ cell tumors .p-u 196 to 727 531 to 1 exact     531/531
(100 %)
1 diff
(99.9 %id)
BE884766 leiomyosarcoma, uterus .e 475 to 1185 1 to 712       712/847
(84 %)
22 diff
(97.5 %id)
BE892665 melanotic melanoma, skin .e 126 to 623 1 to 501       501/579
(86 %)
3 diff
(99.5 %id)
BE897895 melanotic melanoma, skin .d 1399 to 1740 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
BC021991 Brain, glioblastoma .a 1311 to 2536 4 to 1229   available from MGC, AAA   1226/1227
(99 %)
2 diff
(99.9 %id)
BF688046 brain, glioblastoma .a 1311 to 1971 1 to 670   available from MGC,   670/697
(96 %)
41 diff
(94.2 %id)
BF541548 hypernephroma, Kidney .a 1463 to 2118 1 to 640       640/849
(75 %)
27 diff
(96.9 %id)
BF247612 hypernephroma, Kidney .a 1903 to 2428 1 to 527       527/538
(97 %)
11 diff
(98.0 %id)
BF218810 brain, glioblastoma .a 944 to 1603 1 to 651       651/839
(77 %)
39 diff
(95.4 %id)
BF338197 brain, glioblastoma with EGFR amplification .e 136 to 933 1 to 808       808/1000
(80 %)
18 diff
(98.2 %id)
BI816813 brain, glioblastoma with EGFR amplification .e 136 to 768 1 to 634       634/634
(100 %)
2 diff
(99.7 %id)
BF526520 brain, glioblastoma with EGFR amplification .e 180 to 990 1 to 815       815/1151
(70 %)
17 diff
(98.6 %id)
BG033503 breast, mammary adenocarcinoma, cell line .h 1 to 730 1 to 725 E131N Y132T H133T D135T A136P ... tiling clone,   725/806
(89 %)
11 diff
(98.7 %id)
BG168238 hypernephroma, cell line, Kidney .a 348 to 929 1 to 586   tiling clone,   586/1103
(53 %)
9 diff
(99.2 %id)
BG283566 adenocarcinoma, cell line, Prostate .e 454 to 1141 1 to 690       690/690
(100 %)
4 diff
(99.5 %id)
BG566171 Liver .e 360 to 1022 1 to 673       673/1062
(63 %)
27 diff
(97.5 %id)
BI092113 cervix .a 1567 to 2420 1 to 854       854/896
(95 %)
36 diff
(96.0 %id)
BI257480 cervical carcinoma cell line, cervix .d 1183 to 1759 1 to 575   AAA   575/586
(98 %)
13 diff
(97.8 %id)
BI547451 brain, hippocampus .b 327 to 841 1 to 513       513/513
(100 %)
3 diff
(99.5 %id)
BI596498 brain, hypothalamus .d 1 to 715 1 to 715       715/717
(99 %)
6 diff
(99.2 %id)
BI600290 brain, hypothalamus .o 1 to 791 1 to 788 A43S D135T A136P S137Q A138P ... tiling clone,   788/788
(100 %)
12 diff
(98.5 %id)
BI670366 brain, hypothalamus .o 1 to 783 1 to 789 A43S tiling clone,   789/796
(99 %)
23 diff
(97.2 %id)
BI857852 breast, mammary adenocarcinoma, cell line .e 827 to 1343 1 to 524       524/547
(95 %)
10 diff
(98.2 %id)
BM009181 amelanotic melanoma, cell line, skin .c 9 to 807 1 to 805   tiling clone,   805/865
(93 %)
11 diff
(98.8 %id)
BM914752 amelanotic melanoma, cell line, skin .c 1 to 935 1 to 954 E227K M232D E234K E235G E236R ... tiling clone,   954/1108
(86 %)
34 diff
(97.0 %id)
BM550658 melanotic melanoma, skin .e 95 to 1091 1 to 1000 Q189X K195X E200R L208F Q209T ...     1000/1077
(92 %)
19 diff
(98.3 %id)
BM559008 eye, retinoblastoma .k 1 to 884 1 to 886 exact tiling clone, AAA   886/886
(100 %)
9 diff
(99.0 %id)
BM857515 insulinoma, Pancreas .d 734 to 1260 542 to 16   tiling clone, AAA   527/527
(100 %)
0 diff
(100 %id)
BM857739 insulinoma, Pancreas .d 55 to 493 35 to 473       439/473
(92 %)
6 diff
(98.8 %id)
BM142162 Islets of Langerhans, Pancreas .d 1237 to 1746 1 to 510       510/510
(100 %)
2 diff
(99.7 %id)
CK819933 Islets of Langerhans, Pancreas .d 1221 to 1561 1 to 341       341/341
(100 %)
2 diff
(99.5 %id)
BM918738 pooled pancreas and spleen .e 58 to 633 56 to 632       577/1416
(40 %)
25 diff
(98.3 %id)
BQ001098 lung, Metastatic Chondrosarcoma .d 1340 to 1766 449 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 431/436
(98 %)
4 diff
(99.1 %id)
BQ014020 Chondrosarcoma, Left Pubic Bone .d 989 to 1759 769 to 1       769/769
(100 %)
4 diff
(99.5 %id)
BQ001505 lung, Metastatic Chondrosarcoma .e 612 to 1341 747 to 19   AAA   729/729
(100 %)
1 diff
(99.9 %id)
CB215453 normal endometrium, late proliferativephase, cycle day 13, uterus .e 300 to 944 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BU075670 insulinoma, Pancreas .d 1269 to 1766 512 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 497/497
(100 %)
2 diff
(99.6 %id)
BU948210 insulinoma, Pancreas .d 1197 to 1766 583 to 15   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 569/569
(100 %)
4 diff
(99.3 %id)
BU948478 insulinoma, Pancreas .d 33 to 607 1 to 575     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 575/575
(100 %)
4 diff
(99.4 %id)
BU176081 eye, retinoblastoma .b 5 to 423 1 to 419   tiling clone,   419/933
(44 %)
7 diff
(99.3 %id)
BQ954926 sciatic nerve .a 598 to 1203 1 to 614       614/1170
(52 %)
11 diff
(99.1 %id)
BU151106 eye, normal pigmented retinal epithelium .c 49 to 769 1 to 725       725/954
(75 %)
12 diff
(98.8 %id)
BQ641833 eye, normal pigmented retinal epithelium .n 1 to 660 1 to 660   tiling clone,   660/980
(67 %)
8 diff
(99.2 %id)
CB178560 Pancreas, Purified pancreatic islet .e 467 to 1023 10 to 566   fully sequenced,   557/566
(98 %)
6 diff
(99.0 %id)
CB178811 Pancreas, Purified pancreatic islet .e 993 to 1346 356 to 3   fully sequenced,   354/356
(99 %)
6 diff
(98.4 %id)
BU537838 mixed (pool of 40 RNAs) .d 1113 to 1764 1 to 655       655/749
(87 %)
14 diff
(98.2 %id)
BU928322 brain, glioblastoma .d 1117 to 1720 1 to 619       619/850
(72 %)
22 diff
(97.5 %id)
CX870444 embryonic stem .a 1832 to 2535 734 to 30   AAA Submitted on the opposite strand 705/707
(99 %)
0 diff
(100 %id)
DN602026 human embryonic stem cells .b 130 to 776 1 to 647   tiling clone,   647/647
(100 %)
0 diff
(100 %id)
DN601931 human embryonic stem cells .b 87 to 538 1 to 452       452/452
(100 %)
0 diff
(100 %id)
CX762450 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 30 to 721 1 to 684     Submitted on the opposite strand 687/737
(93 %)
17 diff
(97.7 %id)
DR159535 human embryonic stem cells differentiated toan early endodermal cell type .e 33 to 810 1 to 778       778/778
(100 %)
0 diff
(100 %id)
CD107347 brain, Pituitary .i 1 to 640 18 to 659 Q156A E157R Q158T I159N D160* tiling clone,   642/978
(65 %)
11 diff
(98.9 %id)
CF552121 Pooled muscle (cardiac and skeletal) .a 3064 to 3923 1 to 867       867/867
(100 %)
9 diff
(99.0 %id)
CF619037 Pooled Chondrosarcoma Tumor cells .e 361 to 1020 9 to 670       662/934
(70 %)
23 diff
(97.6 %id)
CF129592 Chondrosarcoma Lung Metastasis cell lines, lung .e 842 to 1337 1 to 496   AAA   496/496
(100 %)
0 diff
(100 %id)
TI_44168406   .b 327 to 841 86 to 598       513/598
(85 %)
6 diff
(99.0 %id)
TI_45209357   .d 6 to 715 90 to 799       710/801
(88 %)
8 diff
(99.1 %id)
TI_45215280   .o 6 to 791 146 to 928 A43S D135T A136P S137Q A138P ...     783/928
(84 %)
11 diff
(98.9 %id)
TI_44343807   .o 6 to 783 90 to 873 A43S     784/880
(89 %)
23 diff
(97.4 %id)
TI_57190942   .e 827 to 1343 53 to 576       524/801
(65 %)
10 diff
(98.8 %id)
TI_59383898   .c 10 to 807 68 to 871   AAA   804/855
(94 %)
10 diff
(98.9 %id)
CB161148 Liver .p-u 97 to 721 1 to 625 exact     625/625
(100 %)
0 diff
(100 %id)
DA659297   .a 1 to 455 2 to 456   tiling clone, capped   455/455
(100 %)
0 diff
(100 %id)
BG938627 Bone, Hip .p-u 127 to 690 572 to 9 exact     564/572
(98 %)
0 diff
(100 %id)
NM_003692.3   .b 327 to 2611 1 to 2285 exact RefSeq,   2285/2285
(100 %)
0 diff
(100 %id)
NM_080655.1   .e 180 to 1337 1 to 1158 exact RefSeq, AAA   1158/1158
(100 %)
0 diff
(100 %id)
NM_001018116.1   .a 2956 to 5578 1 to 2623   RefSeq, AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 2623/2623
(100 %)
0 diff
(100 %id)
AU129475   .a 662 to 1378 2 to 724   capped   723/723
(100 %)
12 diff
(98.4 %id)
DB366757   .a 2006 to 2537 532 to 1       532/577
(92 %)
3 diff
(99.5 %id)
DA754273   .a 1871 to 2392 2 to 523   fully sequenced, capped   522/522
(100 %)
0 diff
(100 %id)
DB325173   .a 2362 to 2537 177 to 1   fully sequenced,   177/177
(100 %)
1 diff
(99.5 %id)
DC372848   .a 2519 to 3064 1 to 546   tiling clone,   546/546
(100 %)
3 diff
(99.5 %id)
DA760682   .n 237 to 792 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA764852 tongue .n 589 to 1153 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB325431 tongue .n 1998 to 2578 584 to 1       584/584
(100 %)
7 diff
(98.9 %id)
DC378899 pericardium .a 2981 to 3534 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
DC426441 pericardium .a 5065 to 5578 514 to 1   tiling clone,   514/514
(100 %)
0 diff
(100 %id)
DC379197 pericardium .a 2982 to 3541 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
DC379306 pericardium .a 2981 to 3540 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
DC379728 pericardium .a 2981 to 3562 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP325898 prostata .e 171 to 750 1 to 580       580/580
(100 %)
4 diff
(99.4 %id)
DA888387   .n 544 to 1115 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BM841942 myeloma .e 255 to 810 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BM854314 stomach .e 413 to 770 1 to 358       358/358
(100 %)
0 diff
(100 %id)
TI_1948093241   .b 436 to 1148 130 to 842       713/1417
(50 %)
17 diff
(98.9 %id)
TI_1948093395   .b 436 to 1278 128 to 971       844/1435
(58 %)
31 diff
(97.9 %id)
DN997778 breast cancer, Mammary gland (cancer tissue) .a 2992 to 3568 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
DN994340 brain, whole brain .f 1 to 686 1 to 685   tiling clone,   685/685
(100 %)
5 diff
(99.3 %id)
DN991602 brain, whole brain .f 132 to 761 10 to 639       630/639
(98 %)
6 diff
(99.1 %id)
DN997651 breast cancer, Mammary gland (cancer tissue) .a 3001 to 3552 9 to 560       552/560
(98 %)
6 diff
(99.0 %id)
DB055596 testis .b 526 to 1110 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DB100115 testis .j-u 1 to 585 2 to 586   tiling clone, capped   585/585
(100 %)
2 diff
(99.7 %id)
DB341952 testis .j-u 3701 to 4218 541 to 24       518/541
(95 %)
0 diff
(100 %id)
DB123495 thymus .q-u 1 to 504 2 to 506   tiling clone, capped   505/505
(100 %)
1 diff
(99.9 %id)
TI_149288393   .e 368 to 1330 1017 to 64   AAA   954/1028
(92 %)
23 diff
(97.8 %id)
TI_154065601   .d 108 to 754 57 to 707     Submitted on the opposite strand 649/707
(91 %)
44 diff
(93.8 %id)
TI_154123581   .d 1372 to 1766 482 to 88   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 395/975
(40 %)
6 diff
(99.4 %id)
TI_154191325   .p-u 97 to 725 57 to 686 exact tiling clone, AAA   630/686
(91 %)
6 diff
(99.2 %id)
TI_227712956   .e 397 to 1341 1022 to 83   AAA   940/1039
(90 %)
16 diff
(98.5 %id)
TI_227713496   .e 390 to 1341 1018 to 81   AAA   936/1028
(91 %)
16 diff
(98.5 %id)
TI_227714589   .e 365 to 1341 1062 to 87   AAA   976/1044
(93 %)
25 diff
(97.7 %id)
U19878 brain .b 423 to 1934 153 to 1667 E7Q R11G P16S P17A L18R ...     1515/1665
(90 %)
16 diff
(99.1 %id)
BU681367 lung .e 650 to 1330 698 to 19   AAA   680/680
(100 %)
2 diff
(99.8 %id)
CA312049 Human Lung Epithelial cells, lung .d 1512 to 1766 272 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 254/273
(93 %)
5 diff
(98.2 %id)
CA312807 Human Lung Epithelial cells, lung .e 986 to 1341 374 to 19   AAA   356/365
(97 %)
1 diff
(99.8 %id)
CB243351 Human Lung Epithelial cells, lung .d 1385 to 1766 399 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 382/382
(100 %)
2 diff
(99.5 %id)
BM718343 eye, fetal eye .d 240 to 859 1 to 620   tiling clone, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
BU741931 eye, fetal eye .d 1112 to 1766 673 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 655/655
(100 %)
0 diff
(100 %id)
CA419039 Chondrosarcoma Grade II, Left Pelvis .d 1384 to 1766 401 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 383/383
(100 %)
2 diff
(99.5 %id)
CA425719 cell lines, Chondrosarcoma .p-u 138 to 725 603 to 16 exact AAA   588/588
(100 %)
0 diff
(100 %id)
BU625891 cell lines, Enchondroma .d 1052 to 1766 733 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
BQ776266 Bone, Human Chondrosarcoma Cell Line .p-u 145 to 725 596 to 16 exact AAA   581/581
(100 %)
0 diff
(100 %id)
BU619044 Cell Line, Chondrosarcoma .p-u 146 to 725 595 to 16 exact AAA   580/580
(100 %)
0 diff
(100 %id)
BU617035 Cell Line, Chondrosarcoma .d 1051 to 1766 734 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 716/731
(97 %)
1 diff
(99.9 %id)
CA429959 Cell Line, Chondrosarcoma .p-u 102 to 725 638 to 16 exact AAA   623/625
(99 %)
5 diff
(99.2 %id)
BU620865 Cell Line, Chondrosarcoma .d 1052 to 1766 734 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 716/716
(100 %)
1 diff
(99.9 %id)
CD365253 Alveolar Macrophage, lung .e 582 to 1341 774 to 17   AAA   758/758
(100 %)
2 diff
(99.8 %id)
CD364475 Alveolar Macrophage, lung .p-u 52 to 729 695 to 19 exact AAA   677/677
(100 %)
1 diff
(99.9 %id)
CD367317 Alveolar Macrophage, lung .e 623 to 1341 736 to 19   AAA   718/718
(100 %)
1 diff
(99.9 %id)
TI_872700366   .a 3000 to 3743 1 to 746       746/756
(98 %)
8 diff
(99.0 %id)
X83961 brain .b 423 to 1934 153 to 1667 E7Q R11G P16S P17A L18R ...     1515/1665
(90 %)
16 diff
(99.1 %id)
DA304444 hippocampus .d 1269 to 1766 512 to 16   capped This clone was ignored 497/497
(100 %)
2 diff
(99.6 %id)
DB308170 hippocampus .d 1269 to 1766 512 to 16     This clone was ignored 497/497
(100 %)
2 diff
(99.6 %id)
AV729278 hypothalamus .d 1197 to 1766 583 to 15     Suspected internal deletion, this clone was ignored 569/569
(100 %)
4 diff
(99.3 %id)
AA443378   .d 1197 to 1766 583 to 15     This clone was ignored 569/569
(100 %)
4 diff
(99.3 %id)
AA446953   .d 33 to 607 1 to 575     This clone was ignored 575/575
(100 %)
4 diff
(99.4 %id)
BF576120 muscle (skeletal) .d 33 to 607 1 to 575     This clone was ignored 575/575
(100 %)
4 diff
(99.4 %id)
BU176081 eye, retinoblastoma .b 5 to 423 1 to 419   tiling clone,   419/933
(44 %)
7 diff
(99.3 %id)
BU176081 eye, retinoblastoma .b 5 to 423 1 to 419   tiling clone,   419/933
(44 %)
7 diff
(99.3 %id)
BQ954926 sciatic nerve .a 598 to 1203 1 to 614       614/1170
(52 %)
11 diff
(99.1 %id)
BU151106 eye, normal pigmented retinal epithelium .c 49 to 769 1 to 725       725/954
(75 %)
12 diff
(98.8 %id)
BU151106 eye, normal pigmented retinal epithelium .c 49 to 769 1 to 725       725/954
(75 %)
12 diff
(98.8 %id)
BQ641833 eye, normal pigmented retinal epithelium .n 1 to 660 1 to 660   tiling clone,   660/980
(67 %)
8 diff
(99.2 %id)
BQ641833 eye, normal pigmented retinal epithelium .n 1 to 660 1 to 660   tiling clone,   660/980
(67 %)
8 diff
(99.2 %id)
CB178560 Pancreas, Purified pancreatic islet .e 467 to 1023 10 to 566   fully sequenced,   557/566
(98 %)
6 diff
(99.0 %id)
CB178560 Pancreas, Purified pancreatic islet .e 467 to 1023 10 to 566   fully sequenced,   557/566
(98 %)
6 diff
(99.0 %id)
CB178811 Pancreas, Purified pancreatic islet .e 993 to 1346 356 to 3   fully sequenced,   354/356
(99 %)
6 diff
(98.4 %id)
CB178811 Pancreas, Purified pancreatic islet .e 993 to 1346 356 to 3   fully sequenced,   354/356
(99 %)
6 diff
(98.4 %id)
BU537838 mixed (pool of 40 RNAs) .d 1113 to 1764 1 to 655       655/749
(87 %)
14 diff
(98.2 %id)
BU928322 brain, glioblastoma .d 1117 to 1720 1 to 619       619/850
(72 %)
22 diff
(97.5 %id)
BU928322 brain, glioblastoma .d 1117 to 1720 1 to 619       619/850
(72 %)
22 diff
(97.5 %id)
CX870444 embryonic stem .a 1832 to 2535 734 to 30   AAA Submitted on the opposite strand 705/707
(99 %)
0 diff
(100 %id)
DN602026 human embryonic stem cells .b 130 to 776 1 to 647   tiling clone,   647/647
(100 %)
0 diff
(100 %id)
DN601931 human embryonic stem cells .b 87 to 538 1 to 452       452/452
(100 %)
0 diff
(100 %id)
CX762450 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 30 to 721 1 to 684     Submitted on the opposite strand 687/737
(93 %)
17 diff
(97.7 %id)
CX762450 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 30 to 721 1 to 684     Submitted on the opposite strand 687/737
(93 %)
17 diff
(97.7 %id)
DR159535 human embryonic stem cells differentiated toan early endodermal cell type .e 33 to 810 1 to 778       778/778
(100 %)
0 diff
(100 %id)
CD107347 brain, Pituitary .i 1 to 640 18 to 659 Q156A E157R Q158T I159N D160* tiling clone,   642/978
(65 %)
11 diff
(98.9 %id)
CD107347 brain, Pituitary .i 1 to 640 18 to 659 Q156A E157R Q158T I159N D160* tiling clone,   642/978
(65 %)
11 diff
(98.9 %id)
CF552121 Pooled muscle (cardiac and skeletal) .a 3064 to 3923 1 to 867       867/867
(100 %)
9 diff
(99.0 %id)
CF619037 Pooled Chondrosarcoma Tumor cells .e 361 to 1020 9 to 670       662/934
(70 %)
23 diff
(97.6 %id)
CF129592 Chondrosarcoma Lung Metastasis cell lines, lung .e 842 to 1337 1 to 496   AAA   496/496
(100 %)
0 diff
(100 %id)
CF129592 Chondrosarcoma Lung Metastasis cell lines, lung .e 842 to 1337 1 to 496   AAA   496/496
(100 %)
0 diff
(100 %id)
TI_44168406   .b 327 to 841 86 to 598       513/598
(85 %)
6 diff
(99.0 %id)
TI_45209357   .d 6 to 715 90 to 799       710/801
(88 %)
8 diff
(99.1 %id)
TI_45215280   .o 6 to 791 146 to 928 A43S D135T A136P S137Q A138P ...     783/928
(84 %)
11 diff
(98.9 %id)
TI_44343807   .o 6 to 783 90 to 873 A43S     784/880
(89 %)
23 diff
(97.4 %id)
TI_57190942   .e 827 to 1343 53 to 576       524/801
(65 %)
10 diff
(98.8 %id)
TI_59383898   .c 10 to 807 68 to 871   AAA   804/855
(94 %)
10 diff
(98.9 %id)
CB161148 Liver .p-u 97 to 721 1 to 625 exact     625/625
(100 %)
0 diff
(100 %id)
DA659297   .a 1 to 455 2 to 456   tiling clone, capped   455/455
(100 %)
0 diff
(100 %id)
BG938627 Bone, Hip .p-u 127 to 690 572 to 9 exact     564/572
(98 %)
0 diff
(100 %id)
BG938627 Bone, Hip .p-u 127 to 690 572 to 9 exact     564/572
(98 %)
0 diff
(100 %id)
NM_003692.3   .b 327 to 2611 1 to 2285 exact RefSeq,   2285/2285
(100 %)
0 diff
(100 %id)
NM_080655.1   .e 180 to 1337 1 to 1158 exact RefSeq, AAA   1158/1158
(100 %)
0 diff
(100 %id)
NM_001018116.1   .a 2956 to 5578 1 to 2623   RefSeq, AAA Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) 2623/2623
(100 %)
0 diff
(100 %id)
AU129475   .a 662 to 1378 2 to 724   capped   723/723
(100 %)
12 diff
(98.4 %id)
DB366757   .a 2006 to 2537 532 to 1       532/577
(92 %)
3 diff
(99.5 %id)
DA754273   .a 1871 to 2392 2 to 523   fully sequenced, capped   522/522
(100 %)
0 diff
(100 %id)
DB325173   .a 2362 to 2537 177 to 1   fully sequenced,   177/177
(100 %)
1 diff
(99.5 %id)
DC372848   .a 2519 to 3064 1 to 546   tiling clone,   546/546
(100 %)
3 diff
(99.5 %id)
DA760682   .n 237 to 792 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA764852 tongue .n 589 to 1153 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB325431 tongue .n 1998 to 2578 584 to 1       584/584
(100 %)
7 diff
(98.9 %id)
DC378899 pericardium .a 2981 to 3534 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
DC426441 pericardium .a 5065 to 5578 514 to 1   tiling clone,   514/514
(100 %)
0 diff
(100 %id)
DC379197 pericardium .a 2982 to 3541 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
DC379306 pericardium .a 2981 to 3540 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
DC379728 pericardium .a 2981 to 3562 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP325898 prostata .e 171 to 750 1 to 580       580/580
(100 %)
4 diff
(99.4 %id)
DA888387   .n 544 to 1115 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BM841942 myeloma .e 255 to 810 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BM854314 stomach .e 413 to 770 1 to 358       358/358
(100 %)
0 diff
(100 %id)
TI_1948093241   .b 436 to 1148 130 to 842       713/1417
(50 %)
17 diff
(98.9 %id)
TI_1948093395   .b 436 to 1278 128 to 971       844/1435
(58 %)
31 diff
(97.9 %id)
DN997778 breast cancer, Mammary gland (cancer tissue) .a 2992 to 3568 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
DN997778 breast cancer, Mammary gland (cancer tissue) .a 2992 to 3568 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
DN994340 brain, whole brain .f 1 to 686 1 to 685   tiling clone,   685/685
(100 %)
5 diff
(99.3 %id)
DN994340 brain, whole brain .f 1 to 686 1 to 685   tiling clone,   685/685
(100 %)
5 diff
(99.3 %id)
DN991602 brain, whole brain .f 132 to 761 10 to 639       630/639
(98 %)
6 diff
(99.1 %id)
DN991602 brain, whole brain .f 132 to 761 10 to 639       630/639
(98 %)
6 diff
(99.1 %id)
DN997651 breast cancer, Mammary gland (cancer tissue) .a 3001 to 3552 9 to 560       552/560
(98 %)
6 diff
(99.0 %id)
DN997651 breast cancer, Mammary gland (cancer tissue) .a 3001 to 3552 9 to 560       552/560
(98 %)
6 diff
(99.0 %id)
DB055596 testis .b 526 to 1110 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DB100115 testis .j-u 1 to 585 2 to 586   tiling clone, capped   585/585
(100 %)
2 diff
(99.7 %id)
DB341952 testis .j-u 3701 to 4218 541 to 24       518/541
(95 %)
0 diff
(100 %id)
DB123495 thymus .q-u 1 to 504 2 to 506   tiling clone, capped   505/505
(100 %)
1 diff
(99.9 %id)
TI_149288393   .e 368 to 1330 1017 to 64   AAA   954/1028
(92 %)
23 diff
(97.8 %id)
TI_154065601   .d 108 to 754 57 to 707     Submitted on the opposite strand 649/707
(91 %)
44 diff
(93.8 %id)
TI_154123581   .d 1372 to 1766 482 to 88   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 395/975
(40 %)
6 diff
(99.4 %id)
TI_154191325   .p-u 97 to 725 57 to 686 exact tiling clone, AAA   630/686
(91 %)
6 diff
(99.2 %id)
TI_227712956   .e 397 to 1341 1022 to 83   AAA   940/1039
(90 %)
16 diff
(98.5 %id)
TI_227713496   .e 390 to 1341 1018 to 81   AAA   936/1028
(91 %)
16 diff
(98.5 %id)
TI_227714589   .e 365 to 1341 1062 to 87   AAA   976/1044
(93 %)
25 diff
(97.7 %id)
U19878 brain .b 423 to 1934 153 to 1667 E7Q R11G P16S P17A L18R ...     1515/1665
(90 %)
16 diff
(99.1 %id)
BU681367 lung .e 650 to 1330 698 to 19   AAA   680/680
(100 %)
2 diff
(99.8 %id)
CA312049 Human Lung Epithelial cells, lung .d 1512 to 1766 272 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 254/273
(93 %)
5 diff
(98.2 %id)
CA312049 Human Lung Epithelial cells, lung .d 1512 to 1766 272 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 254/273
(93 %)
5 diff
(98.2 %id)
CA312807 Human Lung Epithelial cells, lung .e 986 to 1341 374 to 19   AAA   356/365
(97 %)
1 diff
(99.8 %id)
CA312807 Human Lung Epithelial cells, lung .e 986 to 1341 374 to 19   AAA   356/365
(97 %)
1 diff
(99.8 %id)
CB243351 Human Lung Epithelial cells, lung .d 1385 to 1766 399 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 382/382
(100 %)
2 diff
(99.5 %id)
CB243351 Human Lung Epithelial cells, lung .d 1385 to 1766 399 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 382/382
(100 %)
2 diff
(99.5 %id)
BM718343 eye, fetal eye .d 240 to 859 1 to 620   tiling clone, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
BM718343 eye, fetal eye .d 240 to 859 1 to 620   tiling clone, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
BU741931 eye, fetal eye .d 1112 to 1766 673 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 655/655
(100 %)
0 diff
(100 %id)
BU741931 eye, fetal eye .d 1112 to 1766 673 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 655/655
(100 %)
0 diff
(100 %id)
CA419039 Chondrosarcoma Grade II, Left Pelvis .d 1384 to 1766 401 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 383/383
(100 %)
2 diff
(99.5 %id)
CA419039 Chondrosarcoma Grade II, Left Pelvis .d 1384 to 1766 401 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 383/383
(100 %)
2 diff
(99.5 %id)
CA425719 cell lines, Chondrosarcoma .p-u 138 to 725 603 to 16 exact AAA   588/588
(100 %)
0 diff
(100 %id)
CA425719 cell lines, Chondrosarcoma .p-u 138 to 725 603 to 16 exact AAA   588/588
(100 %)
0 diff
(100 %id)
BU625891 cell lines, Enchondroma .d 1052 to 1766 733 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
BU625891 cell lines, Enchondroma .d 1052 to 1766 733 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
BQ776266 Bone, Human Chondrosarcoma Cell Line .p-u 145 to 725 596 to 16 exact AAA   581/581
(100 %)
0 diff
(100 %id)
BQ776266 Bone, Human Chondrosarcoma Cell Line .p-u 145 to 725 596 to 16 exact AAA   581/581
(100 %)
0 diff
(100 %id)
BU619044 Cell Line, Chondrosarcoma .p-u 146 to 725 595 to 16 exact AAA   580/580
(100 %)
0 diff
(100 %id)
BU619044 Cell Line, Chondrosarcoma .p-u 146 to 725 595 to 16 exact AAA   580/580
(100 %)
0 diff
(100 %id)
BU617035 Cell Line, Chondrosarcoma .d 1051 to 1766 734 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 716/731
(97 %)
1 diff
(99.9 %id)
BU617035 Cell Line, Chondrosarcoma .d 1051 to 1766 734 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 716/731
(97 %)
1 diff
(99.9 %id)
CA429959 Cell Line, Chondrosarcoma .p-u 102 to 725 638 to 16 exact AAA   623/625
(99 %)
5 diff
(99.2 %id)
CA429959 Cell Line, Chondrosarcoma .p-u 102 to 725 638 to 16 exact AAA   623/625
(99 %)
5 diff
(99.2 %id)
BU620865 Cell Line, Chondrosarcoma .d 1052 to 1766 734 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 716/716
(100 %)
1 diff
(99.9 %id)
BU620865 Cell Line, Chondrosarcoma .d 1052 to 1766 734 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 716/716
(100 %)
1 diff
(99.9 %id)
CD365253 Alveolar Macrophage, lung .e 582 to 1341 774 to 17   AAA   758/758
(100 %)
2 diff
(99.8 %id)
CD365253 Alveolar Macrophage, lung .e 582 to 1341 774 to 17   AAA   758/758
(100 %)
2 diff
(99.8 %id)
CD364475 Alveolar Macrophage, lung .p-u 52 to 729 695 to 19 exact AAA   677/677
(100 %)
1 diff
(99.9 %id)
CD364475 Alveolar Macrophage, lung .p-u 52 to 729 695 to 19 exact AAA   677/677
(100 %)
1 diff
(99.9 %id)
CD367317 Alveolar Macrophage, lung .e 623 to 1341 736 to 19   AAA   718/718
(100 %)
1 diff
(99.9 %id)
CD367317 Alveolar Macrophage, lung .e 623 to 1341 736 to 19   AAA   718/718
(100 %)
1 diff
(99.9 %id)
TI_872700366   .a 3000 to 3743 1 to 746       746/756
(98 %)
8 diff
(99.0 %id)
X83961 brain .b 423 to 1934 153 to 1667 E7Q R11G P16S P17A L18R ...     1515/1665
(90 %)
16 diff
(99.1 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p-u, .q-u, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC